Conservation in vivo of Protease Cleavage Sites in Antigenic Sites of Poliovirus

References

1. Blondel B., Akacem O., Crainic R., Couillin P., Horodniceanu F. 1983; Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and heat-inactivated virions. Virology 126:707–710
   [Google Scholar]
2. Blondel B., Crainic R., Fichot O., Dufraisse G., Cardrea A, Horaud F. 1986; Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody binding site. Journal of Virology 57:81–90
   [Google Scholar]
3. Diamond D. C., Jameson B. A., Brown J., Kohara M., Abe S., Itoh H., Komatsu T., Arita M., Kuge S., Osterhaus A. D. M. E., Crainic R., Nomoto A., Wimmer E. 1985; Antigenic variation and resistance to neutralization in poliovirus type 1. Science 229:1090–1093
   [Google Scholar]
4. Evans D. M. A., Minor P. D., Schild G. C., Almond J. W. 1983; Critical role of an eight amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature; London: 304459–462
   [Google Scholar]
5. Ferguson M., Qi Y-H., Minor P. D., Magrath D. I., Spitz M., Schild G. C. 1982; Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3. Lancet ii:122–124
   [Google Scholar]
6. Ferguson M., Minor P. D., Magrath D. I., Qi Y-H., Spitz M., Schild G. C. 1984; Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies. Journal of General Virology 65:197–201
   [Google Scholar]
7. Ferguson M., Evans D. M. A., Magrath D. I., Minor P. D., Almond J. W., Schild G. C. 1985; Induction of broadly reactive type specific neutralising antibody to poliovirus type 3 by synthetic peptides. Virology 143:505–515
   [Google Scholar]
8. Fox J. P. 1958; Epidemiology of poliomyelitis in populations before and after vaccination with inactivated viruses. In Poliomyelitis: Papers and Discussions Presented at the Fourth International Poliomyelitis Congress pp. 136–149 Philadelphia: J. B. Lippincott Company;
   [Google Scholar]
9. Fricks C. E., Icenogle J. P., Hogle J. M. 1985; Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. Journal of Virology 54:856–859
   [Google Scholar]
10. Gearing A. J. H., Thorpe R., Spitz L., Spitz M. 1985; Use of ‘single shot’ intrasplenic immunization technique for the production of monoclonal antibodies specific for human IgM. Journal of Immunological Methods 76:337–343
    [Google Scholar]
11. Hogle J. M., Chow M., Filman D. J. 1985; The three dimensional structure of poliovirus at 2·9 Å resolution. Science 229:1358–1365
    [Google Scholar]
12. Huovilainen A., Hovi T., Kinnunen L., Takkinen K., Ferguson M., Minor P. 1987; Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. Journal of General Virology 68:1373–1378
    [Google Scholar]
13. Icenogle J. P., Minor P. D., Ferguson M., Hogle J. M. 1986; Modulation of humoral response to a 12-amino acid site on the poliovirion. Journal of Virology 60:297–301
    [Google Scholar]
14. Magrath D. I., Evans D. M. A., Ferguson M., Schild G. C., Minor P. D., Horaud F., Crainic R., Stenvik M., Hovi T. 1986; Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population. Journal of General Virology 67:899–905
    [Google Scholar]
15. Makoff A. j., Paynter C. A., Rowlands D. J., Boothroyd J. C. 1982; Comparison of the amino acid sequence of the major immunogen from three serotypes of foot-and-mouth disease virus. Nucleic Acids Research 10:8285–8295
    [Google Scholar]
16. Minor P. D. 1980; Comparative biochemical studies of type 3 poliovirus. Journal of Virology 34:73–84
    [Google Scholar]
17. Minor P. D., Schild G. C., Bootman J., Evans D. M. A., Ferguson M., Reeve P., Spitz M., Stanway G., Cann A. J., Hauptmann R., Clarke L. D., Mountford R. C., Almond J. W. 1983; Location and primary structure of a major antigenic site for poliovirus neutralization. Nature; London: 301674–679
    [Google Scholar]
18. Minor P. D., Evans D. M. A., Ferguson M., Schild G. C., Westrop G., Almond J. W. 1985; Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. Journal of General Virology 66:1159–1165
    [Google Scholar]
19. Minor P. D., Ferguson M., Evans D. M. A., Almond J. W., Icenogle J. P. 1986a; Antigenic structure of polioviruses of serotypes 1, 2 and 3. Journal of General Virology 67:1283–1291
    [Google Scholar]
20. Minor P. D., John A., Ferguson M., Icenogle J. P. 1986b; Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. Journal of General Virology 67:693–706
    [Google Scholar]
21. Nathanson N., Martin J. R. 1979; The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity and disappearance. American Journal of Epidemiology 110:672–697
    [Google Scholar]
22. Nomoto A., Omata T., Toyoda H., Kuge S., Horie H., Kataoka Y., Genda X., Nakano Y., Imura N. 1982; Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proceedings of the National Academy of Sciences, U.S.A 79:5793–5797
    [Google Scholar]
23. Wiley D. C., Wilson I. A., Skehel J. J. 1981; Structural identification of the antibody binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature; London: 289373–378
    [Google Scholar]